Pharmacologic Intervention to Prevent Graft Failure

This publication has 53 references indexed in Scilit:

• Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty
  Drugs, 1993
• HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Pharmacology of smooth muscle cell replication.
  Hypertension, 1992
• Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty
  The American Journal of Cardiology, 1992
• Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.
  Hypertension, 1991
• Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
  American Heart Journal, 1989
• Avoiding Early Failure of Tibial Prosthetic Bypass Grafts
  The Thoracic and Cardiovascular Surgeon, 1987
• Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty
  American Heart Journal, 1985
• In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets
  The American Journal of Cardiology, 1983